CompletedNot Applicable

Intensive Therapies in Children With Hemiplegia

Spain41 participantsStarted 2018-10-15

Plain-language summary

This is a comparative study where two protocols of intensive therapies will be applied to study the improvements in the functional performance of the affected upper limb of children with hemiparesis and check whether to increase their quality of life.

Who can participate

Age range5 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children diagnosed with Unilateral Infantile Cerebral Palsy, Congenital Infantile Hemiparesis. * Ages between 5 to 10 years. * Levels of I-III within the , manual ability classification system, MACS. * Levels of I-III within the gross motor function classification system, GMFCS Exclusion Criteria: \- Diseases not associated with infantile hemiparesis. * Low cognitive level to understand the execution of activities. * Surgeries of the upper extremity during the 6 months prior to the intervention. * Structured contractures in the affected upper extremity that cause functional impotence. * Botulinum toxin two months prior to the intervention and application of it during the treatment. * Epilepsy not controlled pharmacologically

What they're measuring

bimanual functional performance, "change" is being assessed

Timeframe: 4 assessments will be carried out in the research in 10 weeks

Trial details

NCT IDNCT03465046

SponsorUniversity of Salamanca

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11-25

View on ClinicalTrials.gov More Infantile Hemiplegia trials